Benchling AI debuts alongside major new capabilities for antibody discovery, automated data analysis, and development BOSTON, Oct. 14, 2025 /PRNewswire/ -- Benchling today unveiled major new ...
Investors are eager for the Benchling IPO. The company made headlines when it confidentially filed with the SEC to go public. Biotechnology is rewriting life as we know it. Our customers, spanning ...
SAN FRANCISCO and BOSTON, May 7, 2025 /PRNewswire/ -- Benchling, the R&D platform powering the biotech industry, today announced an expanded collaboration with Moderna. What began with Benchling ...